通过健康信息技术(health IT)实现药物管理。

K Ann McKibbon, Cynthia Lokker, Steve M Handler, Lisa R Dolovich, Anne M Holbrook, Daria O'Reilly, Robyn Tamblyn, Brian J Hemens, Runki Basu, Sue Troyan, Pavel S Roshanov, Norman P Archer, Parminder Raina
{"title":"通过健康信息技术(health IT)实现药物管理。","authors":"K Ann McKibbon,&nbsp;Cynthia Lokker,&nbsp;Steve M Handler,&nbsp;Lisa R Dolovich,&nbsp;Anne M Holbrook,&nbsp;Daria O'Reilly,&nbsp;Robyn Tamblyn,&nbsp;Brian J Hemens,&nbsp;Runki Basu,&nbsp;Sue Troyan,&nbsp;Pavel S Roshanov,&nbsp;Norman P Archer,&nbsp;Parminder Raina","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The objective of the report was to review the evidence on the impact of health information technology (IT) on all phases of the medication management process (prescribing and ordering, order communication, dispensing, administration and monitoring as well as education and reconciliation), to identify the gaps in the literature and to make recommendations for future research.</p><p><strong>Data sources: </strong>We searched peer-reviewed electronic databases, grey literature, and performed hand searches. Databases searched included MEDLINE®, Embase, CINAHL (Cumulated Index to Nursing and Allied Health Literature), Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, Compendex, Inspec (which includes IEEE Xplore), Library and Information Science Abstracts, E-Prints in Library and Information Science, PsycINFO, Sociological Abstracts, and Business Source Complete. Grey literature searching involved Internet searching, reviewing relevant Web sites, and searching electronic databases of grey literatures. AHRQ also provided all references in their e-Prescribing, bar coding, and CPOE knowledge libraries.</p><p><strong>Methods: </strong>Paired reviewers looked at citations to identify studies on a range of health IT used to assist in the medication management process (MMIT) during multiple levels of screening (titles and abstracts, full text and final review for assignment of questions and data abstrction). Randomized controlled trials and cohort, case-control, and case series studies were independently assessed for quality. All data were abstracted by one reviewer and examined by one of two different reviewers with content and methods expertise.</p><p><strong>Results: </strong>40,582 articles were retrieved. After duplicates were removed, 32,785 articles were screened at the title and abstract phase. 4,578 full text articles were assessed and 789 articles were included in the final report. Of these, 361 met only content criteria and were listed without further abstraction. The final report included data from 428 articles across the seven key questions. Study quality varied according to phase of medication management. Substantially more studies, and studies with stronger comparative methods, evaluated prescribing and monitoring. Clinical decision support systems (CDSS) and computerized provider order entry (CPOE) systems were studied more than any other application of MMIT. Physicians were more often the subject of evaluation than other participants. Other health care professionals, patients, and families are important but not studied as thoroughly as physicians. These nonphysicians groups often value different aspects of MMIT, have diverse needs, and use systems differently. Hospitals and ambulatory clinics were well-represented in the literature with less emphasis placed on long-term care facilities, communities, homes, and nonhospital pharmacies. Most studies evaluated changes in process and outcomes of use, usability, and knowledge, skills, and attitudes. Most showed moderate to substantial improvement with implementation of MMIT. Economics studies and those with clinical outcomes were less frequently studied. Those articles that did address economics and clinical outcomes often showed equivocal findings on the effectiveness and cost-effectiveness of MMIT systems. Qualitative studies provided evidence of strong perceptions, both positive and negative, of the effects of MMIT and unintended consequences. We found little data on the effects of forms of medications, conformity, standards, and open source status. Much descriptive literature discusses implementation issues but little strong evidence exists. Interest is strong in MMIT and more groups and institutions will implement systems in the next decades, especially with the Federal Government's push toward more health IT to support better and more cost-effective health care.</p><p><strong>Conclusions: </strong>MMIT is well-studied, although on closer examination of the literature the evidence is not uniform across phases of medication management, groups of people involved, or types of MMIT. MMIT holds the promise of improved processes; clinical and economics studies and the understanding of sustainability issues are lacking.</p>","PeriodicalId":72991,"journal":{"name":"Evidence report/technology assessment","volume":" 201","pages":"1-951"},"PeriodicalIF":0.0000,"publicationDate":"2011-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781568/pdf/","citationCount":"0","resultStr":"{\"title\":\"Enabling medication management through health information technology (Health IT).\",\"authors\":\"K Ann McKibbon,&nbsp;Cynthia Lokker,&nbsp;Steve M Handler,&nbsp;Lisa R Dolovich,&nbsp;Anne M Holbrook,&nbsp;Daria O'Reilly,&nbsp;Robyn Tamblyn,&nbsp;Brian J Hemens,&nbsp;Runki Basu,&nbsp;Sue Troyan,&nbsp;Pavel S Roshanov,&nbsp;Norman P Archer,&nbsp;Parminder Raina\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>The objective of the report was to review the evidence on the impact of health information technology (IT) on all phases of the medication management process (prescribing and ordering, order communication, dispensing, administration and monitoring as well as education and reconciliation), to identify the gaps in the literature and to make recommendations for future research.</p><p><strong>Data sources: </strong>We searched peer-reviewed electronic databases, grey literature, and performed hand searches. Databases searched included MEDLINE®, Embase, CINAHL (Cumulated Index to Nursing and Allied Health Literature), Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, Compendex, Inspec (which includes IEEE Xplore), Library and Information Science Abstracts, E-Prints in Library and Information Science, PsycINFO, Sociological Abstracts, and Business Source Complete. Grey literature searching involved Internet searching, reviewing relevant Web sites, and searching electronic databases of grey literatures. AHRQ also provided all references in their e-Prescribing, bar coding, and CPOE knowledge libraries.</p><p><strong>Methods: </strong>Paired reviewers looked at citations to identify studies on a range of health IT used to assist in the medication management process (MMIT) during multiple levels of screening (titles and abstracts, full text and final review for assignment of questions and data abstrction). Randomized controlled trials and cohort, case-control, and case series studies were independently assessed for quality. All data were abstracted by one reviewer and examined by one of two different reviewers with content and methods expertise.</p><p><strong>Results: </strong>40,582 articles were retrieved. After duplicates were removed, 32,785 articles were screened at the title and abstract phase. 4,578 full text articles were assessed and 789 articles were included in the final report. Of these, 361 met only content criteria and were listed without further abstraction. The final report included data from 428 articles across the seven key questions. Study quality varied according to phase of medication management. Substantially more studies, and studies with stronger comparative methods, evaluated prescribing and monitoring. Clinical decision support systems (CDSS) and computerized provider order entry (CPOE) systems were studied more than any other application of MMIT. Physicians were more often the subject of evaluation than other participants. Other health care professionals, patients, and families are important but not studied as thoroughly as physicians. These nonphysicians groups often value different aspects of MMIT, have diverse needs, and use systems differently. Hospitals and ambulatory clinics were well-represented in the literature with less emphasis placed on long-term care facilities, communities, homes, and nonhospital pharmacies. Most studies evaluated changes in process and outcomes of use, usability, and knowledge, skills, and attitudes. Most showed moderate to substantial improvement with implementation of MMIT. Economics studies and those with clinical outcomes were less frequently studied. Those articles that did address economics and clinical outcomes often showed equivocal findings on the effectiveness and cost-effectiveness of MMIT systems. Qualitative studies provided evidence of strong perceptions, both positive and negative, of the effects of MMIT and unintended consequences. We found little data on the effects of forms of medications, conformity, standards, and open source status. Much descriptive literature discusses implementation issues but little strong evidence exists. Interest is strong in MMIT and more groups and institutions will implement systems in the next decades, especially with the Federal Government's push toward more health IT to support better and more cost-effective health care.</p><p><strong>Conclusions: </strong>MMIT is well-studied, although on closer examination of the literature the evidence is not uniform across phases of medication management, groups of people involved, or types of MMIT. MMIT holds the promise of improved processes; clinical and economics studies and the understanding of sustainability issues are lacking.</p>\",\"PeriodicalId\":72991,\"journal\":{\"name\":\"Evidence report/technology assessment\",\"volume\":\" 201\",\"pages\":\"1-951\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781568/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence report/technology assessment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence report/technology assessment","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本报告的目的是审查关于卫生信息技术(IT)对药物管理过程所有阶段(开处方和订购、订单沟通、调剂、管理和监测以及教育和和解)影响的证据,确定文献中的差距,并为今后的研究提出建议。数据来源:我们检索了同行评议的电子数据库、灰色文献,并进行了手工检索。检索的数据库包括MEDLINE®、Embase、CINAHL(护理和相关健康文献累积索引)、Cochrane系统评价数据库、国际药物摘要、Compendex、Inspec(包括IEEE Xplore)、图书馆与信息科学摘要、图书馆与信息科学电子打印、PsycINFO、社会学摘要和Business Source Complete。灰色文献检索包括网络检索、相关网站检索和灰色文献电子数据库检索。AHRQ还提供了其电子处方、条形码和CPOE知识库中的所有参考文献。方法:配对审稿人查看引文,以确定在多个筛选阶段(标题和摘要、全文和问题分配和数据摘要的最终审查)中用于协助药物管理过程(MMIT)的一系列健康信息技术的研究。随机对照试验、队列、病例对照和病例系列研究均独立评估质量。所有数据由一位审稿人抽取,并由两位具有内容和方法专业知识的审稿人中的一位进行检查。结果:共检索到40582篇文献。在删除重复后,在标题和摘要阶段筛选了32,785篇文章。评估了4 578篇全文文章,并将789篇文章列入最后报告。其中,361只符合内容标准,没有进一步的抽象。最终报告包含了涉及7个关键问题的428篇文章的数据。研究质量随用药管理阶段的不同而不同。更多的研究,以及更强有力的比较方法的研究,评估了处方和监测。临床决策支持系统(CDSS)和计算机化提供者订单输入(CPOE)系统的研究比MMIT的任何其他应用都要多。医生比其他参与者更常成为评估的对象。其他卫生保健专业人员、病人和家庭也很重要,但没有像医生那样深入研究。这些非医生群体通常重视MMIT的不同方面,有不同的需求,并以不同的方式使用系统。医院和门诊在文献中有很好的代表性,而对长期护理设施、社区、家庭和非医院药房的重视程度较低。大多数研究评估了使用过程和结果、可用性、知识、技能和态度的变化。大多数人在实施MMIT后表现出中度到实质性的改善。经济学研究和具有临床结果的研究较少。那些讨论经济学和临床结果的文章经常在MMIT系统的有效性和成本效益方面显示模棱两可的结果。定性研究提供了证据,证明人们对MMIT的影响和意外后果有强烈的认识,无论是积极的还是消极的。我们发现很少有关于药物形式、一致性、标准和开放源代码状态的影响的数据。许多描述性文献讨论了实施问题,但很少有强有力的证据存在。人们对MMIT非常感兴趣,未来几十年将有更多的团体和机构实施该系统,特别是随着联邦政府推动更多的医疗信息技术,以支持更好、更具成本效益的医疗保健。结论:MMIT得到了充分的研究,尽管对文献进行更仔细的检查,证据在药物管理的各个阶段、涉及的人群或MMIT的类型上并不统一。MMIT承诺改进流程;缺乏临床和经济学研究以及对可持续性问题的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Enabling medication management through health information technology (Health IT).

Objectives: The objective of the report was to review the evidence on the impact of health information technology (IT) on all phases of the medication management process (prescribing and ordering, order communication, dispensing, administration and monitoring as well as education and reconciliation), to identify the gaps in the literature and to make recommendations for future research.

Data sources: We searched peer-reviewed electronic databases, grey literature, and performed hand searches. Databases searched included MEDLINE®, Embase, CINAHL (Cumulated Index to Nursing and Allied Health Literature), Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, Compendex, Inspec (which includes IEEE Xplore), Library and Information Science Abstracts, E-Prints in Library and Information Science, PsycINFO, Sociological Abstracts, and Business Source Complete. Grey literature searching involved Internet searching, reviewing relevant Web sites, and searching electronic databases of grey literatures. AHRQ also provided all references in their e-Prescribing, bar coding, and CPOE knowledge libraries.

Methods: Paired reviewers looked at citations to identify studies on a range of health IT used to assist in the medication management process (MMIT) during multiple levels of screening (titles and abstracts, full text and final review for assignment of questions and data abstrction). Randomized controlled trials and cohort, case-control, and case series studies were independently assessed for quality. All data were abstracted by one reviewer and examined by one of two different reviewers with content and methods expertise.

Results: 40,582 articles were retrieved. After duplicates were removed, 32,785 articles were screened at the title and abstract phase. 4,578 full text articles were assessed and 789 articles were included in the final report. Of these, 361 met only content criteria and were listed without further abstraction. The final report included data from 428 articles across the seven key questions. Study quality varied according to phase of medication management. Substantially more studies, and studies with stronger comparative methods, evaluated prescribing and monitoring. Clinical decision support systems (CDSS) and computerized provider order entry (CPOE) systems were studied more than any other application of MMIT. Physicians were more often the subject of evaluation than other participants. Other health care professionals, patients, and families are important but not studied as thoroughly as physicians. These nonphysicians groups often value different aspects of MMIT, have diverse needs, and use systems differently. Hospitals and ambulatory clinics were well-represented in the literature with less emphasis placed on long-term care facilities, communities, homes, and nonhospital pharmacies. Most studies evaluated changes in process and outcomes of use, usability, and knowledge, skills, and attitudes. Most showed moderate to substantial improvement with implementation of MMIT. Economics studies and those with clinical outcomes were less frequently studied. Those articles that did address economics and clinical outcomes often showed equivocal findings on the effectiveness and cost-effectiveness of MMIT systems. Qualitative studies provided evidence of strong perceptions, both positive and negative, of the effects of MMIT and unintended consequences. We found little data on the effects of forms of medications, conformity, standards, and open source status. Much descriptive literature discusses implementation issues but little strong evidence exists. Interest is strong in MMIT and more groups and institutions will implement systems in the next decades, especially with the Federal Government's push toward more health IT to support better and more cost-effective health care.

Conclusions: MMIT is well-studied, although on closer examination of the literature the evidence is not uniform across phases of medication management, groups of people involved, or types of MMIT. MMIT holds the promise of improved processes; clinical and economics studies and the understanding of sustainability issues are lacking.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review. Data Linkage Strategies to Advance Youth Suicide Prevention. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Health Information Exchange. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1